Swedish Biotech Breakthroughs

Ascelia Pharma

Market Cap: SEK 256.6m

A biotech company, focuses on orphan oncology treatments in Sweden.

Elicera Therapeutics

Market Cap: SEK 103.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.6b

Develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

BioArctic

Market Cap: SEK 15.5b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

SenzaGen

Market Cap: SEK 142.8m

Provides non-animal tests for assessing a substance’s allergenicity.

Active Biotech

Market Cap: SEK 94.7m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.5b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

BioInvent International

Market Cap: SEK 1.8b

A clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Mendus

Market Cap: SEK 280.0m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Modus Therapeutics Holding

Market Cap: SEK 46.7m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.